A propensity-matched analysis comparing hepatic recurrence after curative gastrectomy followed by adjuvant HIPEC to surgery alone for advanced gastric cancer.

Authors

null

Satoshi Murata

Department of Surgery, Shiga University of Medical Science, Otsu, Japan

Satoshi Murata , Sachiko Kaida , Hirokazu Kodama , Hiroshi Yamamoto , Tsuyoshi Yamaguchi , Reiko Ohtake , Masaji Tani

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Citation

J Clin Oncol 34, 2016 (suppl; abstr 4056)

DOI

10.1200/JCO.2016.34.15_suppl.4056

Abstract #

4056

Poster Bd #

48

Abstract Disclosures

Similar Posters

First Author: Satoshi Murata

Poster

2017 ASCO Annual Meeting

Pathophysiology and therapeutic strategies for peritoneal recurrence after gastric cancer surgery.

Pathophysiology and therapeutic strategies for peritoneal recurrence after gastric cancer surgery.

First Author: Satoshi Murata

Poster

2024 ASCO Gastrointestinal Cancers Symposium

A phase II trial of CapeOX plus nivolumab for early relapsed HER2-negative gastric cancer (JACCRO GC-11: FirSTAR trial).

A phase II trial of CapeOX plus nivolumab for early relapsed HER2-negative gastric cancer (JACCRO GC-11: FirSTAR trial).

First Author: Hiroyuki Arai